A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found ...

Cambridge’s DIOSynVax and Singapore’s ACM Biolabs will be jointly developing a next-generation universal bird flu vaccine with the potential for mucosal delivery to combat the next pandemic. This ...

A nanoparticle-based vaccine candidate for H5N1 avian influenza achieved 100% protection in preclinical trials, offering hope ...

A made-in- Hamilton COVID vaccine that requires no needles is moving to the next stage of testing and researchers are looking for volunteers to take part. The vaccine that is inhaled instead of ...

A decade of data shows that switching to a recombinant flu vaccine could prevent up to 10,000 hospitalizations per year in ...

Lead researcher and CEO of POP Biotechnologies, Dr. Jonathan Lovell, is based at the University at Buffalo. Dr. Lovell said ...

Explainer - Flu season is almost here. Here's what you need to know about the different vaccine options.

This was also the first year since the start of the COVID-19 pandemic that deaths from flu surpassed deaths from COVID.

After giving nearly 4000 vaccinations to Tasmanians in 2024 - earning her the nickname 'Needle Ninja' - a Launceston nurse ...

The company has also filed for FDA approval of its flu+Covid combination vaccine, mRNA-1083. If approved, it will be the first in the US to offer protection against flu and Covid-19 in a single shot.

An infectious disease physician says the pace of the flu vaccine rollout for vulnerable groups is "disappointing" amid concerns the 2025 season will be the worst yet.